Team
Our team has +50 years of combined experience in Aging, Regenerative Medicine, & Drug Development
Salah Mahmoudi, PhD
Co-founder | CEO
Dr. Mahmoudi leads the company’s mission to develop breakthrough therapeutics for the aging brain. With 20+ years in life sciences R&D, he has led drug discovery teams at Pfizer and Alkahest and co-authored 19+ papers in Nature, Science, and Cell. A biotech entrepreneur, he co-founded NoraChem and advises multiple AI-driven biotech startups. At ReneuBio, he drives strategy, fundraising, and partnerships to advance brain regeneration and recovery.
Tyson Ruetz, PhD
Co-founder | Scientific Advisor
Dr. Ruetz is the developer of our Target Discovery Engine and lead author on its publication in Nature. With over a decade of experience in aging and regenerative medicine, he has pioneered in vivo screening in the brain, uncovering novel therapeutic targets for neurodegenerative diseases. His expertise drives our platform’s innovation, enabling the discovery of small molecules tailored to the aging brain.
Ramil Baiazitov, PhD
Head of Chemistry
Dr. Baiazitov leads ReneuBio’s chemistry efforts, bringing +18 years of expertise in small-molecule drug discovery. A seasoned medicinal chemist, he has contributed to the development of four CNS-penetrant clinical candidates, with one successfully reaching the market. His deep knowledge in drug design, optimization, and translational development ensures our small molecules advance efficiently from bench to clinic.
Stylianos Kyriacou, PhD
AI/Technology Advisor
Dr. Kyriacou advises ReneuBio on the integration of AI-driven approaches for designing small molecule therapeutics. With a unique background spanning aerospace engineering and computational drug discovery, he has developed cutting-edge platforms for small molecule and peptide design. His expertise bridges engineering principles with biomedical innovation, accelerating the discovery of novel therapeutics for brain regeneration and repair.
Kurtis Knapp
Legal
Kurtis Knapp provides legal guidance to ReneuBio, leveraging his extensive experience in supporting ventures through all stages of their lifecycle. With a deep understanding of corporate law, fundraising, and biotech regulations, he ensures strategic legal alignment as the company grows and advances its mission in brain therapeutics.
